TipRanks
Travere Therapeutics (DE:17R)
BERLIN:17R
Germany Market
17R
Travere Therapeutics
RESEARCH TOOLSreports

Travere Therapeutics (17R) Balance Sheet

2 Followers

Travere Therapeutics Balance Sheet

Travere Therapeutics's total assets for Q2 2026 were $799.36M, an increase of 43.98% from the previous quarter. DE:17R total liabilities were $774.84M for the fiscal quarter, a 69.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 605.19M$ 594.13M$ 788.91M$ 672.59M$ 776.63M
Total Liabilities
$ 490.36M$ 535.05M$ 588.10M$ 629.73M$ 474.52M
Total Equity Gross Minority
$ 114.83M$ 59.08M$ 200.81M$ 42.85M$ 302.11M
Other Metrics
Currency in USD

Travere Therapeutics Debt to Assets